Antabio

Healthcare & Life Sciences

Recent Finacing

Series B

Recent Raise

$26.9M

Antabio is a French biopharmaceutical company developing novel treatments for drug-resistant bacterial infections, with a focus on life-threatening respiratory conditions and a portfolio that includes a metallo beta-lactamase inhibitor.